Physician profile
Jonathan Patterson
NPI 1316646557
$1,104.28
in general payments reported to CMS, 2019-2025
16 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.60 · 2024: $665 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.79 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $290.81 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $136.95 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $111.49 | 2024 | |
| Gilead Sciences, INC. | $91.13 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $90.00 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $69.22 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.37 | 2024-2025 | Jardiance |
| Lundbeck LLC | $44.21 | 2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $39.53 | 2023-2024 | Xarelto |
| Amgen INC. | $32.43 | 2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $30.67 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $29.31 | 2024-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $24.67 | 2025 | Rexulti |
| Ani Pharmaceuticals, INC. | $23.05 | 2025 | Purified Cortrophin Gel |
| Corcept Therapeutics | $19.97 | 2025 | Korlym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $16.47 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.